Galactosylceramide, glucosylceramide, lactosylceramide and its specific catcher for use in the prevention or treatment of prediabetes, diabetes and / or related complications

摘要

The use of glycolipids, in particular galactosylceramide, glucosylceramide and lactosylceramide, and specific catchers therefor (antibodies or lectins), in particular monoclonal antibodies, for use in the prophylaxis or therapy of prediabetes, diabetes and/or associated complications in an individual and for use in the production of pharmaceutical preparations for treatment of said conditions is disclosed.